Bhopal Medical Visit
Doctors deplore long-term health effects of the tragedy

In January an international medical commission visited Bhopal. More than 4,000 have now died as a result of the methyl isocyanate leak from the Union Carbide plant producing the insecticide aldicarb. The independent group of doctors found long-term ill-health in a substantial part of the population. They criticised the withholding of information which could help victims, and health policies which concentrated on hospital building rather than basic care. Eye and breathing problems continue, as well as severe memory loss. The latter is often unrecognised and does not entitle victims to compensation.
    The Medical Commission found that while Indian doctors have done a great deal of research, they have been prevented from publishing it, initially because of pending court cases. This has made it impossible to chart the effects of the gas, to assess the best forms of treatment, or even to give a reliable figure of those badly affected. The 15 doctors said it was immoral to do research on people and then to withhold results that could benefit them. They urged the Bhopal health authorities to stop building hospitals and to move towards more basic health care.
    So far, only a tiny proportion of the US$470 million in compensation, agreed between Union Carbide and the Indian Government, has been paid to victims. It is expected to take another 20 years before all the claims are heard. The impact on the community has been drastic, according to Talmiz Ahmed of the Indian High Commission in London, who has visited the area.

BBC World Service, 12 January 1994.

[This article first appeared in Pesticides News No. 23, March 1994, page 10]